Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen

OBJECTIVE: The association between UGT1A1*6/*28 polymorphisms and treatment outcomes of irinotecan in children remains unknown. This retrospective study investigated the influence of UGT1A1*6/*28 polymorphisms on irinotecan toxicity and survival of pediatric patients with relapsed/refractory solid t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaoqin, Zhu, Jia, Sun, Feifei, Zhen, Zijun, Zhou, Dalei, Lu, Suying, Huang, Junting, Que, Yi, Zhang, Lian, Cai, Ruiqing, Wang, Juan, Zhang, Yizhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001723/
https://www.ncbi.nlm.nih.gov/pubmed/33790625
http://dx.doi.org/10.2147/PGPM.S292556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001723/
https://www.ncbi.nlm.nih.gov/pubmed/33790625
http://dx.doi.org/10.2147/PGPM.S292556

Ejemplares similares